USA - NASDAQ:OLMA - US68062P1066 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to OLMA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-08 | Guggenheim | Initiate | Buy |
| 2025-09-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-08-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-19 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-07 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-02 | Goldman Sachs | Initiate | Buy |
| 2024-03-12 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-30 | Citigroup | Initiate | Buy |
| 2023-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-06 | Oppenheimer | Reiterate | Outperform -> Outperform |
14 analysts have analysed OLMA and the average price target is 24.82 USD. This implies a price increase of 209.09% is expected in the next year compared to the current price of 8.03.
The consensus rating for OLEMA PHARMACEUTICALS INC (OLMA) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.